STUDY QUESTION: Is HIV associated with increased time to pregnancy (TTP)?
Introduction
Across sub-Saharan Africa, HIV-positive women have fewer children on average than their HIV-negative counterparts (Zaba and Gregson, 1998; Lewis et al., 2004) . The causes of this discrepancy are complex and involve interactions between cultural, behavioral and physiological influences on fertility intentions and outcomes.
Prior research has identified a number of determinants of HIV on subsequent fecundity and fertility. For example, HIV is associated with several fertility-reducing behaviors, including greater use of contraception and induced abortion (Hoffman et al., 2008; Bankole et al., 2014) , lower desired fertility (Johnson et al., 2009; Bankole et al., 2011) , and higher risk of union dissolution (Porter et al., 2004) . While knowledge of HIV status often precipitates changes in such behaviors (Hoffman et al., 2008; Yeatman, 2009) , some behaviors, like declines in coital frequency, have also been documented among women who likely did not know their status (Ross et al., 2004) .
HIV may also impair reproductive functioning. For example, existing evidence indicates that HIV is associated with higher rates of fetal loss (Brocklehurst and French, 1998) , increased incidence of amenorrhea (Chirgwin et al., 1996) and impaired semen parameters (Nicopoullos et al., 2011) . Moreover, markers of infection duration, such as viral load or CD4 cell count, are also associated with lower pregnancy risk (Ross et al., 2004; Nguyen et al., 2006) .
While prior studies have identified important determinants of the relationship between HIV and fertility, there is a need to better describe and quantify fecundity patterns associated with HIV in the general population while taking into account potential influences of fertility-altering behaviors. Drawing from Demographic and Health Survey (DHS) data from 11 African countries, this population-based study investigates the association between HIV and fecundity by employing a time-to-pregnancy (TTP) study design. As with other TTP studies (Wilcox et al., 1988; Buck Louis et al., 2011) , we limit our analysis to women who report discontinuing a contraceptive method in order to become pregnant, which may lessen potential influences of behavioral responses on fecundity. Additionally, because awareness of HIV status may alter fertility intentions and behaviors (Hoffman et al., 2008) , we separately analyze the association between HIV and TTP by likely knowledge of status.
Materials and Methods

Study population and design
We considered all DHSs that (i) collected dried blood spot samples for HIV testing and (ii) included a contraceptive calendar module where women were asked to provide reasons for discontinuing a contraceptive method.
Data from 12 DHSs conducted between 2003 and 2013 in 11 African countries met the inclusion criteria (see Table I for list of surveys). Data were pooled across all surveys to ensure an adequate sample size for analysis.
Contraceptive calendar data are retrospective month-by-month histories covering a multi-year period prior to the DHS survey. The calendars record women's reproductive status in each month; possible states include pregnancy, birth, termination and contraceptive use or non-use. In any month when a woman reported discontinuing a contraceptive method, she was asked why she discontinued. We limit our study to women who discontinued contraception because they 'wanted to become pregnant' (n = 8269 events), and used the number of months post-discontinuation as our observation period for assessing TTP.
Our main explanatory variable, HIV status, was ascertained from dried blood spots that were collected at the time of the survey; we create a binary indicator for HIV status. To reduce the threat of confounding from behavioral changes following an HIV diagnosis, we also develop an additional explanatory measure that combines HIV status with information on whether respondents had ever been tested for HIV and received their results, which proxies for knowledge of HIV status. The resulting variable was categorized as: (i) HIV-negative and likely knows status; (ii) HIVnegative and likely does not know status; (iii) HIV-positive and likely knows status; and (iv) HIV-positive and likely does not know status.
In TTP studies, fecundability or the likelihood of becoming pregnant per menstrual cycle, is the key parameter of interest (Zegers-Hochschild et al., 2017) . Calendar data allowed us to determine the number of cycles (approximated by months) post-contraceptive discontinuation it took women to become pregnant or if they were unsuccessful during the period of observation. For all observations, TTP intervals began when women discontinued a method in order to attempt pregnancy. Women were followed until a pregnancy occurred (based on self-report) or, if no pregnancy occurred, until 3 months prior to the interview (i.e. censored observations). The latter restriction avoids underestimating pregnancies that had not yet been recognized at the time of the interview. We also accounted for the presence of longer TTP intervals by censoring observations at 12 months.
To reduce the threat of recall bias, we limit our analysis to observations where women discontinued a contraceptive in the 2 years prior to the survey (n = 3248). In addition, if a woman discontinued a contraceptive in order to become pregnant more than once during the study period (n = 45), the most recent observation was used. We also exclude a small number of observations missing data on covariates (n = 22). The final sample size comprised 3181 TTP observations, representing 2544 pregnancies and 12 338 months.
Several potential confounding factors were considered for analysis. To account for reduced fecundability associated with age, we included a categorical variable with the following age classification: 15-19 years old, 20-29 years old, 30-34 years old and over 35. Union status at the time of survey was categorized as currently or not currently in a union. Measures of residence, wealth, and education were included to serve as proxies for access to health care services. Residence was determined from urban/rural classifications for each country. Wealth was defined as a categorical variable according to the DHS wealth quintile classification for each country (i.e. poorest to richest; Rutstein and Johnson, 2004) . Education was categorized as no education, primary education, secondary education or higher education.
The following variables were included as measures of sexual and reproductive health. Parity was classified as 0 (nulliparous), 1, 2, 3, and 4 or more. Lifetime exposure to sex was assessed from self-reported age of first sex (categories: before age 15, 15-19 years old, 20-24 years old and 25 or older.) Polygynous union was measured as a binary indicator (yes/ no); women who responded do not know (1.5% of cases) were classified as polygynous. Recent history of sexually transmitted infection (STI) was assessed from questions asking if participants had an STI or symptoms of an STI (bad smelling abnormal genital discharge or a genital sore or ulcer) in the 12 months prior to the survey; responses were coded as a binary variable (yes/no).
We also considered other measures of health status. BMI was calculated from weight and height data that were measured directly during the interview. BMI was classified according to the International Classification of adult underweight, overweight and obesity (underweight: <18.5; normal range: 18.5-24.99; overweight: 25-29.99; obese: 30 or more). Use of tobacco products was determined from a number of questions assessing cigarette, cigar and chewing tobacco use measured at the time of the survey, which were combined to create a binary indicator for tobacco use.
Hormonal contraception may cause temporary reductions in fecundity following discontinuation (Mansour et al., 2011) . We therefore adjust for the expectant lag in TTP by controlling for the prior method used. Contraceptive methods were classified as hormonal (pill), hormonal (injection or implant), IUD, barrier (diaphragm, condom, foam) or traditional (rhythm, withdrawal.) We do not include women who discontinued the lactational amenorrhea method (LAM) in our analysis.
All covariates, with the exceptions of age and parity, were measured at the time of the survey. Age and parity status correspond to when the woman discontinued contraception. Number of lifetime partners was only available for a subset of surveys, and therefore was not included in the main analyses. Other potential covariates, such as use of antiretroviral (ARV) treatment, partners' characteristics (including partners' HIV status), viral load markers and CD4 cell counts were not available for analysis.
Statistical analyses
We employed bivariate analysis with chi-square tests for categorical variables to provide a descriptive summary of potential confounders and examine associations by HIV status. Covariates that were significantly different by HIV status were examined as potential confounders in multivariable models.
Cox proportional hazard models for discrete survival data were used to model TTP and estimate fecundability odds ratios (FOR) and 95% confidence intervals. In this study, the FOR is the relative odds of becoming pregnant in a given month conditional on not having become pregnant in a previous month; thus, a FOR <1 indicates that the exposed group had longer TTP and decreased fecundability compared to the unexposed group. Preliminary models adjusted for age, union status, education, urban/rural residence, parity, self-reported STI in the 12 months prior to the survey, and prior contraceptive used. Covariates were retained in the final model if their exclusion changed the effect estimate >10% or if there was some evidence of a bivariate association with the outcome (P < 0.10). All models account for right-censoring and include survey fixed effects to control for unobservable characteristics within each country.
The central assumption of the Cox proportional model is that hazards are proportional across the period studied (i.e. regression coefficients do not change over time). Tests of proportionality, including visual inspection of loglog survival plots and statistical tests of interaction terms with time, showed that the proportionality assumption for several covariates, including HIV status, was not upheld in our analytic sample. However, upon further examination, we noted that covariates were proportional in two distinct time periods: ≤3 months and >3 months following contraceptive discontinuation.
Given violation of the proportionality assumption, we use two approaches for presenting our results. First, because the violation is not severe, we model TTP over the entire study period and follow Allison's (1995) interpretation that coefficients represent an average effect over the time period. Second, to account for non-proportionality, we use a piecewise model that allows coefficients to differ by time period but upholds proportionality assumptions within time periods. In the piecewise model, data are split into the two time periods discussed above (≤3 months and >3 months following contraceptive discontinuation). We conducted sensitivity analyses to determine if our findings were robust when (i) the study population was limited to those with at least one birth and those with no prior births; and (ii) we limit analyses to surveys with information on number of lifetime partners. For (ii), a measure of number of lifetime partners was available for all surveys except Kenya 2003 and Malawi 2004; number of reported lifetime partners was coded as 1, 2, 3 or more, with 'don't know' responses classified as 3 or more (<1% of cases).
Additionally, because the increasing availability and use of ARV treatment over the study period (2003-2013) may affect the relationship between HIV and fecundity (Kaida et al., 2006) , we conducted an exploratory analysis that stratifies our sample by two time periods to approximate pre-and post-ARV treatment scale-up in the study countries. We consider all surveys that were fielded before 2010 pre-roll-out (WHO, 2013) .
Custom weights accounting for complex sampling designs were created such that each survey contributes equally to the analysis. Analyses were conducted in Stata 14.0 using the svy suite of commands.
Ethical approval
DHS procedures, surveys, and protocols have been reviewed and approved by the ICF Institutional Review Board (IRB); protocols were also approved by an IRB in each host country. Informed consent was obtained from all participants.
Results
In our sample, 10.3% of women were HIV-positive, and a little more than half (51.8%) of women received test results and likely knew their status. Likely knowledge of status did not differ between HIV-negative and HIV-positive women (52.1 and 49.3%, respectively.) Table II presents descriptive statistics of the study sample by HIV status. Several potential covariates were significantly associated with HIV at the 10% level (i.e. α = 0.10). HIV-positive women were more likely to be well-educated (secondary or higher), live in urban areas, report an STI and use oral contraceptive pills, whereas HIV-negative women were more likely to be in a union at the time of the survey, have four or more children at the time of contraceptive discontinuation, and use injections, implants or traditional methods. HIVnegative women were also more likely to be younger (under 20) or older (35 and above). Wealth status, BMI, tobacco use and age at first sex were not significantly associated with HIV in our sample. Table III shows the adjusted FORs and 95% confidence intervals for the relationship between HIV status and TTP for the entire observation period, and for two separate periods following contraceptive discontinuation (i.e. ≤3 months and >3 months). All models adjust for age, education, urban residence, parity, reporting an STI in previous 12 months, prior contraceptive method used, and survey fixed effects. Over the entire observation period, HIV-positive women had a 25% average reduction in fecundity compared to HIV-negative women [adjusted FOR (aFOR) = 0.75 (0.62-0.92)] after adjusting for confounders. However, reductions in fecundity associated with HIV were not uniform across the 12-month period. Among women who were still trying for pregnancy after 3 unsuccessful months, HIV-positive women had half the odds of becoming pregnant compared to HIV-negative women [aFOR = 0.50 (0.35-0.71)]. There were no significant differences in FORs between HIV-negative and HIV-positive women in the first 3 months. Table IV presents results from models using an alternative specification of HIV status for the same three time periods described in Table III . Here, HIV-negative and positive women are separated into two groups: those who likely knew their status and those who likely did not know their status. In the 12-month period following contraceptive discontinuation, TTP among HIV-positive women who likely knew their status was not significantly different on average from their HIVnegative counterparts. However, HIV-positive women who likely did not know their status (i.e. had never been tested or received results) had reduced odds of becoming pregnant over the 12-month period, whether the reference group for comparison was HIV-negative women who likely knew their status [aFOR = 0.59 (0.45-0.77); Table IV] Results differ when analyses are stratified by time period (i.e. ≤3 months and >3 months). HIV-positive women, regardless of probable knowledge of their status, had significant reductions in fecundity in the latter period.
Results were largely robust in sensitivity analysis. The one exception arose when analyses were limited to nulliparous women; no significant differences were found in fecundity by HIV status among women with no prior births, although the relatively smaller size of this group (n = 200) may have lacked statistical power to detect an association due to the lower prevalence in the general population of primary, rather than secondary, infertility as defined by Mascarenhas et al. (2012) . 
Discussion
Among women who discontinue a contraceptive method to become pregnant, we find that HIV-positive women have a 25% average reduction in fecundity in the 12-month period following discontinuation compared to HIV-negative women. These results are statistically significant in multivariable models that control for known predictors of TTP and HIV status, such as age and self-report of a previous STI.
Importantly, we demonstrate differences in average fecundity patterns over the 12-month period by women's likely knowledge of their status. HIV-positive women who likely do not know their status have significant reductions in fecundity compared to HIV-negative women, but this relationship does not hold for HIV-positive women who likely know their status. While this attenuated effect among women who knew their status may reflect differences infertility behaviors by knowledge of status, it might also indicate differences in overall health and wellbeing. Indeed, knowledge of status likely proxies for other important determinants of fecundity such as underlying health status, behaviors or engagement in health care services-a hypothesis that is corroborated by the finding that knowledge of status is independently associated with enhanced fecundity among HIV-negative women. Moreover, among HIV-positive women, knowledge of HIV status may be associated with better access to health care, receipt of treatment for comorbid infections, and the use of ARV treatment for viral suppression. Women who know their status may also comprise a more fecund group given that HIV testing is often integrated into routine antenatal care (Gunn et al., 2016) , although we find no relationship between nulliparity and knowledge of status in our sample.
The hazard of pregnancy for HIV-positive and negative women was not proportional over the time period studied. Namely, there were no significant differences in the conditional odds of pregnancy by HIV status in the first 3 months following contraceptive discontinuation. Among women who were still attempting pregnancy at 3 months, however, HIV-positive women had markedly reduced fecundity, independent of likely knowledge of status. While women who try for pregnancy after 3 months, regardless of HIV status, are less fecund than those who attempt pregnancy earlier, the latent distribution of waiting times to pregnancy may be right-shifted for HIV-positive women due to differences in health behaviors or underlying health status. For example, after an unsuccessful period of trying for pregnancy, women who are HIVpositive may reduce the number of pregnancy attempts to mitigate the risk of HIV transmission (Matthews and Mukherjee, 2009 ). We also cannot rule out that measurement error in retrospective reporting may have contributed to these patterns, although we restrict our study to the prior 2 years to reduce retrospective reporting bias.
Several mechanisms may explain our findings. For example, existing evidence finds that HIV positivity and severity are associated with a range of female reproductive health problems that may impair fecundity, including higher incidence of menstrual irregularities, comorbid STIs, and tubal blockage (van Leeuwen et al., 2007 , Waters et al., 2007 . In addition, the co-morbidity of HIV and bacterial vaginosis (BV) has been documented, with data showing that the presence of BV increases acquisition of HIV (Atashili et al., 2008) . BV, an infection characterized by an imbalance in the naturally occurring microorganisms of the vagina, is associated with pelvic inflammatory disease, increased susceptibility to STI, infertility and miscarriage, all which impact a woman's fecundity (Mania-Pramanik et al., 2009 , Gallo et al., 2012 , Taylor et al., 2013 , van Oostrum et al., 2013 , McClelland et al., 2018 . Other proposed mechanisms, such as reduced ovarian function, may also play a role, although the evidence base for these relationships is less clear (van Leeuwen et al., 2007) . While we cannot identify the exact mechanism at play in our study, it is worth noting that HIV-positive women were more likely to report recent history of STI than HIV-negative women (16.0 versus 9.1%).
This study contributes to the existing literature in several ways. This is one of the few studies assessing TTP in sub-Saharan Africa (Bello et al., 2010; Polis et al., 2017) and the second known study to use contraceptive calendar data from the DHS to estimate TTP (Polis et al., 2017) . Studies of fecundity and infertility in this region have typically used indirect survey techniques to assess burden (Mascarenhas et al., 2012) . Further, the use of reproductive calendar and pregnancy intention data offer a more direct method for identifying the presence of impaired fertility, since the women in our study state that they actively discontinued a contraceptive method in order to attempt pregnancy.
The second strength of this analysis is that it takes into account potential influences of fertility-altering behaviors associated with HIV Respondent has not been previously tested for HIV or received results.
and comorbidities on reduced fecundity. In addition to studying HIVpositive women who likely did not know their status, we also limit our study to women who intend a pregnancy. Together, these study design choices attempt to control for the latent effects from behavioral responses to the epidemic, such as increased use of contraception, abortion or other behaviors that might affect fertility outcomes (Kaida et al., 2006) . Third, we capitalize on biomarker data, rather than self-reported HIV status, to address substantial underreporting of HIV status in the study region (Fishel et al., 2014) . We also develop a measure of likely knowledge of status from two separate questions assessing if participants had ever been tested for HIV or received results. Although misreporting of these responses is possible, we believe the extent of misclassification bias is smaller than had participants been directly asked to report knowledge of status.
Fourth, although we could not directly ascertain how use of ARV treatment may have contributed to our results, we are able to stratify our sample by time period to approximate pre-versus post-ARV treatment expansion (WHO, 2013) . In this analysis, FORs become marginally significant in the post-ARV treatment sample, suggesting that ARV treatment may lessen the fecundity-reducing effects of HIV. Indeed, prior studies have shown that women with higher viral loads and lower CD4 cell counts are less likely to become pregnant than women in earlier stages of infection (Ross et al., 2004; Nguyen et al., 2006) . However, use of ARV treatment is associated with impaired semen parameters (Frapsauce et al., 2015) . More research is needed to investigate the impacts of ART on reproduction, as a recent review notes there is insufficient evidence to make firm conclusions (Yeatman et al., 2016) .
There are, however, several limitations to this study. First, because dried blood spot samples for HIV testing were collected at the time of the survey but reproductive calendar data were collected retrospectively, it is possible that we introduced misclassification bias, as we have no knowledge if the acquisition of HIV occurred before or after a pregnancy attempt. Indeed, prior research finds that there is persistent HIV risk across the pre-pregnancy, pregnancy and post-partum periods (Drake et al., 2014) . We attempt to reduce this bias by limiting our analysis to women who discontinued a contraceptive method in the 2 years prior to the survey.
Second, pregnancy status is determined by the respondent, not clinical recognition. It is possible, therefore, that some recognized pregnancies, such as those terminated either by spontaneous or induced abortion, were not reported in the reproductive calendar data. Research in Tanzania, for example, suggests that women experiencing adverse pregnancy outcomes may be less likely to report such pregnancies in surveys (Haws et al., 2010) . Moreover, we are unable to determine what mechanisms underlie the reduction of fecundity among HIV-positive women in our sample. It is unclear, for example, if differences in TTP result from differential rates of becoming pregnant or early pregnancy loss.
Third, we chose reported pregnancy, rather than a live birth, as a marker of fecundity in the current study. While prior research indicates that HIV-positive women have higher risk of adverse pregnancy outcomes, we do not feel that Demographic and Health Survey data are adequate to fully consider this relationship given the potential underreporting issues mentioned above. However, we note that limiting our sample to reported pregnancies allowed us to include women who are currently pregnant at the time of the survey.
We limit our study to women who discontinued a contraceptive method in order to attempt pregnancy. As such, results are not readily generalizable to women who do not use contraceptives or women who discontinue contraceptives for other reasons-groups that comprise the majority of pregnancies in these settings. Moreover, we were not able to account for differences in persistence of trying for pregnancy among these women-a factor that has previously been shown to affect TTP (Basso et al., 2000) -nor are we able to account for potential impacts of exclusive breastfeeding, as these factors were not measured in the contraceptive calendar module.
Although the focus of this study has been on the potential effects of HIV on fecundity in women, it should be emphasized that fecundity is a couple-level phenomenon. DHSs and most other population-based datasets, however, do not include pertinent information on partner characteristics, even though HIV and use of ARV treatment are associated with male characteristics and specifically semen parameters that can impact fecundity (Nicopoullos et al., 2011 , Pilatz et al., 2014 , Frapsauce et al., 2015 . Future research should employ a partner-level perspective to assess population-level impacts of HIV and related treatment on fecundity. Until more studies incorporate data collection that includes partner characteristics and better links HIV-related and reproductive health data, we will continue to have a limited understanding of the HIV-fecundity relationship.
As life expectancy and quality health status improve due to earlier initiation of ARV treatment in HIV-positive women, there has been growing awareness that services should also address the fertility desires of HIV-positive women who want children Bujan and Pasquier, 2016) . Despite previous limited attention to the needs of this population (Moragianni, 2014; Mmeje et al., 2016) , recognition appears to be growing for women and couples in resource-constrained settings (Heffron et al., 2015; Narasimhan et al., 2017) . These findings indicate that if a pregnancy does not occur after 3 months of attempting pregnancy, HIV-positive women and HIV-discordant couples, should request access to HIV and reproductive pre-pregnancy counseling and health assessments from their health care provider.
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